检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王宇飞 冯星火[1] WANG Yu-fei;FENG Xing-huo(Department of Critical Care Medicine,Liaoning People’s Hospital,Shenyang 110015,China)
出 处:《中国现代药物应用》2021年第1期106-108,共3页Chinese Journal of Modern Drug Application
摘 要:目的探讨泛耐药鲍曼不动杆菌重症肺炎采用不同剂量替加环素治疗的效果。方法50例泛耐药鲍曼不动杆菌重症肺炎患者,依据替加环素剂量不同分为常规剂量组和增加剂量组,每组25例。常规剂量组患者给予常规剂量替加环素治疗,增加剂量组患者给予增加剂量替加环素治疗。比较两组患者的细菌清除情况、不良反应发生情况。结果增加剂量组患者细菌总清除率为88.0%(22/25),高于常规剂量组的64.0%(16/25),差异具有统计学意义(P<0.05)。增加剂量组患者不良反应发生率为12.0%(3/25),与常规剂量组的8.0%(2/25)比较差异无统计学意义(P>0.05)。结论泛耐药鲍曼不动杆菌重症肺炎采用增加剂量替加环素治疗的效果较常规剂量好。Objective To discuss the effect of different doses of tigecycline on severe pneumonia caused by pan-resistant Acinetobacter baumannii.Methods A total of 50 patients with severe pneumonia caused by pan-resistant Acinetobacter baumannii were divided into conventional dose group and increased dose group according to different doses of tigecycline,with 25 cases in each group.Patients in the conventional dose group were treated with conventional dose of tigecycline,while patients in the increased dose group were treated with increased dose of tigecycline.The bacterial clearance and occurrence of adverse reactions of the two groups were compared.Results The total bacterial clearance rate of increased dose group was 88.0%(22/25),which was higher than 64.0%(16/25)of conventional dose group,and the difference was statistically significant(P<0.05).The incidence of adverse reactions of increased dose group was 12.0%(3/25),which had no statistically significant difference compared with 8.0%(2/25)of conventional dose group(P>0.05).Conclusion Increased dose tigecycline has better effect in the treatment of severe pneumonia caused by pan-resistant Acinetobacter baumannii than conventional dose tigecycline.
关 键 词:不同剂量 替加环素 泛耐药鲍曼不动杆菌重症肺炎 治疗效果
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.254